2M.D. Professor, Trakya University Faculty of Medicine, Department of Ophthalmology, Edirne/TURKEY Purpose: To investigate the efficacy of treatment in Eales' disease.
Material and Methods: Thirty-three eyes of 21 patients at least 11 months followed with a diagnosis of Eales' disease between 1990 to 2012 were retrospectively evaluated. Demographic characteristics, presenting symptoms, examination findings and treatments were evaluated. Fourteen eyes were treated with laser photocoagulation and systemic steroid, 10 were treated with only laser photocoagulation and 3 were treated with only systemic steroid. Four eyes were observed without treatment and 2 eyes underwent pars plana vitrectomy due to vitreous hemorrhage.
Results: The mean age was 36.7±15.7 (15-65). M/F ratio was 2.5. Mean follow-up duration was 84 (11-225) months. It was 57% bilateral. The most common (58.1%) presenting symptom was blurred vision. The most common ophthalmoscopic findings on admission; neovascularization 42%, vitreous hemorrhage 39% and intraretinal hemorrhage 36%. Twenty-one (88%) of 24 eyes treated with laser photocoagulation alone or in combination with systemic steroid were maintained or showed improved vision. Macular edema or epiretinal membrane was seen in 5 of 6 eyes with decreased visual acuity.
Conclusion: Laser photocoagulation treatment of Eales' disease provides a good visual prognosis. Visual prognosis is poor in macular involvement.
Keywords : Eales’ disease; visual prognosis; treatment